文献速递胸部CT

基于人工智能的定量CT特征分析对肺结节病理类型的预测价值

Predictive value of artificial intelligence-based quantitative CT feature analysis for diagnosing the pathological types of pulmonary nodules.
PubMed 文献 · Eur Radiol · 2025-10-11

研究纳入462个经病理确诊的肺结节,利用深度学习AI平台提取影像组学特征(CT衰减、三维形态、纹理参数),构建结合AI特征与传统CT征象的联合模型,区分四种病理类型。联合模型对浸润性腺癌AUC为0.936,对非典型腺瘤样增生+原位腺癌AUC为0.884,对炎性结节AUC为0.865,微浸润腺癌AUC为0.707。

要点

  • 联合模型鉴别浸润性腺癌的AUC达0.936,鉴别非典型腺瘤样增生+原位腺癌的AUC为0.884。
  • 将炎性结节作为独立类别纳入,有助于AI区分良性模仿病变与恶性结节。
  • 熵、实性成分比例和总体积等特征可有效区分浸润性与非浸润性病变。

核心结论

  • 基于AI的定量CT影像组学联合传统CT征象模型对肺结节四种病理类型具有较好预测价值,其中对浸润性腺癌、非典型腺瘤样增生+原位腺癌和炎性结节的AUC分别为0.936、0.884和0.865,微浸润腺癌分类准确性较低(AUC=0.707)。

研究设计与样本

  • 研究纳入462个经病理确诊的肺结节,使用基于深度学习的AI平台提取影像组学特征(CT衰减指标、三维形态学、熵和偏度等纹理参数),采用单变量和多变量策略构建逻辑回归模型,并构建整合AI特征与传统CT征象的联合模型。

关键影像表现/征象

  • 联合模型对浸润性腺癌的AUC为0.936,对非典型腺瘤样增生+原位腺癌的AUC为0.884,对炎性结节的AUC为0.865,对微浸润腺癌的AUC为0.707。

诊断标准与关键数值

  • 联合模型鉴别浸润性腺癌的AUC为0.936,鉴别非典型腺瘤样增生+原位腺癌的AUC为0.884,鉴别炎性结节的AUC为0.865,鉴别微浸润腺癌的AUC为0.707。
  • 熵、实性成分比例和总体积等关键特征可有效区分浸润性与非浸润性病变。

临床应用与阅片要点

  • AI影像组学联合传统CT征象可辅助肺结节术前无创、客观的个体化诊断,有助于术前风险分层并可能减少对良性炎性病变的不必要手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Accurate preoperative classification of pulmonary nodules (PNs) is critical for guiding clinical decision-making and preventing overtreatment. This study aims to evaluate the predictive performance of artificial intelligence (AI)-based quantitative computed tomography (CT) feature analysis in differentiating among four pathological types of PNs: atypical adenomatous hyperplasia and adenocarcinoma in situ (AAH + AIS), minimally invasive adenocarcinoma (MIA), invasive adenocarcinoma (IAC), and lung inflammatory nodules (IN).

MATERIALS AND METHODS: A total of 462 pathologically confirmed PNs were analyzed. Radiomic features, including CT attenuation metrics, 3D morphometrics, and texture parameters such as entropy and skewness, were extracted using a deep learning-based AI platform. Logistic regression models were constructed using both single- and multi-variable strategies to evaluate the classification accuracy of these features. Moreover, the inclusion of IN as a separate category significantly enhanced the clinical utility of AI in differentiating benign mimickers from malignant nodules. The combined model, which integrated AI-derived features with traditional CT signs, was used to assess the diagnostic performance of the radiomic features in differentiating the four pathological types of nodules.

RESULTS: The combined model demonstrated superior diagnostic performance, with area under the curve (AUC) values of 0.936 for IAC, 0.884 for AAH + AIS, and 0.865 for IN. Although MIA showed lower classification accuracy (AUC = 0.707), key features such as entropy, solid component ratio, and total volume effectively distinguished invasive from non-invasive lesions.

CONCLUSION: These findings highlight the potential of AI-enhanced radiomics for supporting non-invasive, objective, and individualized diagnosis of PNs.

KEY POINTS: Question Can artificial intelligence (AI)-based quantitative CT analysis reliably differentiate benign inflammatory nodules from the spectrum of lung adenocarcinoma subtypes, a common diagnostic challenge? Findings An integrated model combining AI-driven radiomic features and traditional CT signs demonstrated high accuracy in differentiating invasive adenocarcinoma (AUC = 0.936), pre-invasive lesions (AUC = 0.884), and inflammatory nodules (AUC = 0.865). Clinical relevance AI-enhanced radiomics provides a non-invasive, objective tool to improve preoperative risk stratification of pulmonary nodules, potentially guiding personalized management and reducing unnecessary surgeries for benign inflammatory lesions that mimic malignancy.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang H, Liu K, Ding Y, et al. Predictive value of artificial intelligence-based quantitative CT feature analysis for diagnosing the pathological types of pulmonary nodules. Eur Radiol. 2025. PMID: 41076471. doi:10.1007/s00330-025-12050-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。